The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Teva Pharmaceutical Industries Ltd. announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the ...
read more
Positive high-level results from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis (prevention) trial showed AstraZeneca’s sipavibart (...
read more
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene ...
read more
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, and Retro Biosciences (Retro), a ...
read more
Enable Injections, Inc. and Serina Therapeutics announced a partnership to develop and commercialize SER-252 (POZ-apomorphine) in combination with ...
read more
Amidst stricter regulatory oversight and closer consumer scrutiny, U.S. product recalls increased eight percent quarter-over-quarter in Q1 2024. ...
read more
Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million through the ...
read more
Centogene N.V. announced the discovery of a new small molecule together with Evotec SE. The new molecule has the potential to treat patients with type...
read more
Boehringer Ingelheim announced an agreement with Quallent Pharmaceuticals, a private label pharmaceutical distributor, to help expand patient access ...
read more
Chiesi Group, a research-oriented international biopharmaceutical group, proudly announces the signing of a memorandum of understanding with ...
read more
Sumitomo Pharma America, Inc. announced that the FDA accepted its supplemental New Drug Application (sNDA) for vibegron (GEMTESA®), a beta-3 ...
read more
Takeda and AC Immune SA announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of...
read more
5 Prime Sciences, a biotechnology data analytics company focused on using human genetics to accelerate drug development, announced a strategic ...
read more
In response to President Biden's Executive Order 14081, "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure ...
read more
evitria AG, a global antibody expression service provider located in Zurich, Switzerland, has entered into a non-exclusive bYlok® bispecific pairing ...
read more